Most Down Articles

    Published in last 1 year | In last 2 years| In last 3 years| All| Most Downloaded in Recent Month | Most Downloaded in Recent Year|

    In last 2 years
    Please wait a minute...
    For Selected: Toggle Thumbnails
    Establishment and investigation of carbon tetrachloride-induced acute liver injury model in mice
    FU Shuang-nan, GAO Da, GUO Jia-jia, MIAO Ming-san, ZHU Ping-sheng, GONG Man
    Chinese Hepatolgy    2022, 27 (9): 1036-1040.  
    Abstract801)      PDF (1030KB)(410)      
    Objective To investigate the stable animal model of carbon tetrachloride (CCl4)-induced acute liver injury in mice, which is convenient for the research and application of new clinical drugs. Methods The Kunming (KM) mice were randomLy divided into blank group, model group, and bifendate group (5.625 mg/kg), and the acute liver injury of mice was replicated by intraperitoneal injection of 0.1% CCl4 solution. The aminotransferase level, liver index, and pathological changes of liver tissue at 3h, 6h, 12h, and 24h after modeling were detected to study the stability of the model. Results After exposure to the model group, alanine aminotransferase (ALT) increased slightly at 3 h [(45.21 ± 13.17) IU/L, P<0.01], and increased significantly at 12 h [(112.30 ± 30.54) IU/L] and 24 h [(121.98 ± 21.66) IU/L] (both P<0.01); AST increased at 3 h [(162.51 ± 28.57) IU/L], 6 h [(192.07 ± 31.05) IU/L], 12 h [(250.75 ± 90.82) IU/L] and 24 h [(274.27 ± 44.02) IU/L] (all P<0.01), but increased significantly at 12 and 24 h; liver index slightly increased at 3 h [(6.72 ± 1.90) g/100 g] and 6h [(6.72 ± 1.90) g/100 g] (both P<0.01). At 12 h [(12.41 ± 1.18) g/100 g] and 24 h [(14.90 ± 2.56) g/100 g] (both P<0.01), the liver pathological changes showed obvious hepatocyte swelling and inflammatory cell infiltration, and the injury degree was more significant at 24 h. Conclusion When the mouse acute liver injury model was prepared by intraperitoneal injection of 0.1% CCl4 solution, the modeling time between 12 h and 24 h was more appropriate.
    Reference | Related Articles | Metrics
    Chinese Hepatolgy    2023, 28 (2): 135-145.  
    Abstract293)      PDF (2000KB)(363)      
    Reference | Related Articles | Metrics
    Chinese Hepatolgy    2022, 27 (7): 725-729.  
    Abstract704)      PDF (699KB)(310)      
    Reference | Related Articles | Metrics
    Chinese Hepatolgy    2022, 27 (8): 940-940.  
    Abstract286)      PDF (640KB)(307)      
    Reference | Related Articles | Metrics
    Chinese Hepatolgy    2023, 28 (1): 1-10.  
    Abstract222)      PDF (1293KB)(278)      
    Reference | Related Articles | Metrics
    Hepatotoxic pyrrolizidine alkaloid detection accurately diagnosed HPA-HSOS
    SHAO You-lin, XIONG Ai-zhen, ZHANG Suo-cai, WU Jian-ming, MA Chun-ming, GUO Feng-cai, LIU Long-gen
    Chinese Hepatolgy    2022, 27 (10): 1112-1115.  
    Abstract107)      PDF (643KB)(276)      
    Objective To investigate the feasibility of detecting hepatotoxic pyrrolizidine alkaloids (HPA) in patients’ ingestion in the diagnosis of HPA-hepatic sinusoidal obstruction syndrome (HSOS). Methods Clinical datas were collected from 1 patient taking Gynura Segetum Lour and 4 patients taking “Sanqi powder” or “Sanqi wine”. Acquity Ultra Performance LCTM-Micromass ZQ 2000(UPLC-MS) was used to determine the levels of six major hepatotoxic pyrrolizidine alkaloids, including seneciphylline, seneciphylline N-oxide, senecionine, senecionine N-oxide, seneciphyllinine and seneciphyllinine N-oxide. Results ① 4 patients were diagnosed with HPA-HSOS, and 1 patient was excluded from HPA-HSOS. ② HPA was found in roots, stems and leaves of Gynura Segetum, and the content of HPA was root > leaf > stem. Conclusion HPA-HSOS can be accurately diagnosed by detecting HPA in patients’ ingestion.
    Reference | Related Articles | Metrics
    Chinese Hepatolgy    2022, 27 (12): 1340-1343.  
    Abstract319)      PDF (795KB)(276)      
    Reference | Related Articles | Metrics
    Chinese Hepatolgy    2023, 28 (1): 25-27.  
    Abstract126)      PDF (713KB)(265)      
    Reference | Related Articles | Metrics
    Chinese Hepatolgy    2023, 28 (2): 148-151.  
    Abstract573)      PDF (723KB)(263)      
    Reference | Related Articles | Metrics
    Chinese Hepatolgy    2022, 27 (10): 1143-1145.  
    Abstract180)      PDF (629KB)(258)      
    Reference | Related Articles | Metrics
    Chinese Hepatolgy    2022, 27 (10): 1059-1061.  
    Abstract218)      PDF (621KB)(249)      
    Reference | Related Articles | Metrics
    Chinese Hepatolgy    2022, 27 (8): 943-945.  
    Abstract74)      PDF (981KB)(242)      
    Reference | Related Articles | Metrics
    Chinese Hepatolgy    2022, 27 (5): 610-611.  
    Abstract123)      PDF (633KB)(241)      
    Reference | Related Articles | Metrics
    Chinese Hepatolgy    2022, 27 (7): 832-833.  
    Abstract169)      PDF (641KB)(236)      
    Reference | Related Articles | Metrics
    Chinese Hepatolgy    2023, 28 (1): 13-16.  
    Abstract133)      PDF (800KB)(236)      
    Reference | Related Articles | Metrics
    Analysis on the influencing factors of gallbladder wall thickening in Wilson's disease-associated cirrhosis
    LI Qi, ZENG A-juan, DING Hui-guo, LI Lei
    Chinese Hepatolgy    2022, 27 (5): 531-535.  
    Abstract152)      PDF (643KB)(235)      
    Objective To investigate influencing factors of gallbladder wall thickening in patients with Wilson's disease (WD) -associated cirrhosis. Methods A total of 82 patients with WD admitted to our hospital were retrospectively enrolled and they were divided into 3 groups: WD-associated compensated cirrhosis group, WD-associated decompensated cirrhosis group and WD without cirrhosis group. Risk factors for gallbladder wall thickening were analyzed. Results Cholecystopathy was common in patients with WD, especially in patients with WD-associated cirrhosis. Compared to the patients with WD-associated compensated cirrhosis, the rates of gallbladder wall thickening (88.23% vs 42.86%, χ2=25.441, P<0.001), cholecystitis (74.29% vs 64.29%, χ2=10.319, P<0.05) and hydrocholecystis (51.43% vs 21.43%, χ2=9.111, P<0.05) were higher in patients with WD-associated decompensated cirrhosis. Course of disease, total bilirubin, direct bilirubin, serum albumin, cholinesterase, high-density lipoprotein-cholesterol, gallbladder wall roughness and hydrocholecystis were significantly associated with gallbladder wall thickening in patients with WD-associated cirrhosis. Multivariate analysis revealed that inside diameter of portal vein and Child-Pugh C were independently risk factors for gallbladder wall thickening in WD-associated cirrhosis. Conclusion Gallbladder wall thickening is common in patients with WD-associated cirrhosis. Inside diameter of portal vein and Child-Pugh C could be independent risk factors for the development of gallbladder wall thickening.
    Reference | Related Articles | Metrics
    Chinese Hepatolgy    2022, 27 (8): 941-942.  
    Abstract182)      PDF (693KB)(233)      
    Reference | Related Articles | Metrics
    Chinese Hepatolgy    2022, 27 (6): 715-719.  
    Abstract176)      PDF (622KB)(232)      
    Reference | Related Articles | Metrics
    Chinese Hepatolgy    2023, 28 (1): 11-13.  
    Abstract118)      PDF (774KB)(230)      
    Reference | Related Articles | Metrics
    Chinese Hepatolgy    2022, 27 (7): 729-732.  
    Abstract245)      PDF (678KB)(228)      
    Reference | Related Articles | Metrics